← Back to Search

Participatory Systems Engagement for Addiction and Mental Health Care

N/A

Waitlist Available

Led By Lindsey E Zimmerman, PhD

Research Sponsored by Palo Alto Veterans Institute for Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-/post- 12-month period average of evidence-based practice reach (24 months total observation)

Awards & highlights

Study Summary

This trial tests if a new method of engaging patients, providers, and policy makers in addiction and mental health care (participatory system dynamics) is more effective than status quo approaches.

Who is the study for?

This trial is for VA divisions and outpatient clinics that are below the median in quality for treating depression, PTSD, and opioid use disorder. They must have at least a year's worth of data from 2018 but not be involved in other specific VA improvement programs or scheduled for EHR updates during the study.Check my eligibility

What is being tested?

The trial tests Participatory System Dynamics (PSD), which involves patients, providers, and policymakers to improve care access against standard methods like Audit and Feedback (AF). It aims to see if PSD can enhance treatment reach within veteran healthcare services.See study design

What are the potential side effects?

Since this trial focuses on system dynamics rather than medical treatments, it does not involve direct patient interventions with physical side effects. However, changes in organizational processes could indirectly affect patient care experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-/post- 12-month period average of evidence-based practice reach (24 months total observation)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-/post- 12-month period average of evidence-based practice reach (24 months total observation)

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-/post- 12-month period average of evidence-based practice reach (24 months total observation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of combination of prescriptions placed with the VA pharmacy and sessions with a relevant CPT code

Proportion of completed evidence-based practice templates during sessions with a relevant CPT code

Proportion of patients diagnosed with alcohol use disorder, depression, opioid use disorder, or PTSD who meet evidence-based psychotherapy and pharmacotherapy initiation and course measures divided by total number of patients with these diagnoses

Secondary outcome measures

Degree of acceptability of intervention assessed by the Acceptability of Intervention Measure (AIM) [followed by its scale information in the Description]

Degree of appropriateness of intervention assessed by the Intervention Appropriateness Measure (IAM) [followed by its scale information in the Description]

Degree of feasibility of intervention assessed by the Feasibility of Intervention Measure (FIM) [followed by its scale information in the Description]

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Participatory System Dynamics (PSD)Experimental Treatment1 Intervention

12 clinics assigned to PSD

Group II: Audit and Feedback (AF)Experimental Treatment1 Intervention

12 clinics assigned to AF

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor

52 Previous Clinical Trials

7,185 Total Patients Enrolled

Lindsey E Zimmerman, PhDPrincipal InvestigatorNational Center for PTSD, Dissemination & Training Division

Media Library

Participatory System Dynamics Clinical Trial Eligibility Overview. Trial Name: NCT04356274 — N/A

Opioid Use Disorder Research Study Groups: Participatory System Dynamics (PSD), Audit and Feedback (AF)

Opioid Use Disorder Clinical Trial 2023: Participatory System Dynamics Highlights & Side Effects. Trial Name: NCT04356274 — N/A

Participatory System Dynamics 2023 Treatment Timeline for Medical Study. Trial Name: NCT04356274 — N/A

Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT04356274 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any more participants being taken on board for this experiment?

"As sourced from clinicaltrials.gov, this medical research is no longer actively recruiting patients; the trial was initially posted on February 1st 2019 and last updated on August 3rd 2021. Despite that, there are still 2597 other trials open to participants at present."

Answered by AI

What is the primary objective of this therapeutic experiment?

"The paramount goal of this two-year study is to determine the effectiveness of evidence-based practices for treating alcohol use disorder, depression, opioid use disorder and PTSD. Secondary objectives will involve analysing demographic measures (e.g., ethnicity and gender) with a 4 item survey as well as assessing psychological safety in workplace settings based on 27 questions from the Learning Organization Survey (LOS-27). Additionally, systems thinking competency across four constructs – complexity, feedback behaviour and time – will be assessed through codebook assessments and session observations."

Answered by AI